An Observational, Prospective, Safety Study of Mircera (Monopegylated Epoetin Beta) in Clinical Practice

NCT02263833 · clinicaltrials.gov ↗

COMPLETED

Status

748

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Disease, Chronic

Interventions

DRUG: Mircera

Sponsor

Hoffmann-La Roche